KRS 304.17A-259: Coverage under health benefit plan for genetic test for cancer risk.

(1) As used in this section, "genetic test for cancer risk" means a blood, saliva, or tissue

typing test that reliably determines the presence or absence of an inherited genetic

characteristic that is generally accepted in the medical or scientific communi ty as

being associated with a statistically significant increased risk of cancer

development.

(2) (a) All health benefit plans issued or renewed on or after January 1, 2020, shall

cover any genetic test for cancer risk that is recommended by any of the

following, if the recommendation is consistent with the most recent version of

genetic testing guidelines published by the National Comprehensive Cancer

Network (NCCN):

1. A physician, physician assistant, or genetic counselor licensed under

KRS Chapter 311; or

2. An advanced practice registered nurse licensed under KRS Chapter 314.

(b) The commissioner may extend the coverage required by paragraph (a) of this

subsection to include recommendations that are consistent with the most

recent version of genetic tes ting guidelines or criteria published by additional

national medical societies, if the guidelines or criteria are determined by the

commissioner to be relevant and reliable.

(3) Coverage required by this section shall:

(a) Not be subject to a deductible, c oinsurance, or any other cost -sharing

requirements; and

(b) Include coverage at the health benefit plan's average in -network rate for out -

of-network providers or laboratories if there are no in -network providers or

laboratories available to provide the covered test.

(4) This section shall not be construed to limit coverage required by KRS 304.17A -257

or any other law.